BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21505208)

  • 1. Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial.
    Wilson DM; Xing D; Cheng J; Beck RW; Hirsch I; Kollman C; Laffel L; Lawrence JM; Mauras N; Ruedy KJ; Tsalikian E; Wolpert H;
    Diabetes Care; 2011 Jun; 34(6):1315-7. PubMed ID: 21505208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.
    Lawson ML; Bradley B; McAssey K; Clarson C; Kirsch SE; Mahmud FH; Curtis JR; Richardson C; Courtney J; Cooper T; Downie CJ; Rajamannar G; Barrowman N; ;
    BMC Pediatr; 2014 Jul; 14():183. PubMed ID: 25034216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous glucose monitoring in children with type 1 diabetes.
    ; Buckingham B; Beck RW; Tamborlane WV; Xing D; Kollman C; Fiallo-Scharer R; Mauras N; Ruedy KJ; Tansey M; Weinzimer SA; Wysocki T
    J Pediatr; 2007 Oct; 151(4):388-93, 393.e1-2. PubMed ID: 17889075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating the A1C assay into estimated average glucose values.
    Nathan DM; Kuenen J; Borg R; Zheng H; Schoenfeld D; Heine RJ;
    Diabetes Care; 2008 Aug; 31(8):1473-8. PubMed ID: 18540046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
    Bergenstal RM; Beck RW; Close KL; Grunberger G; Sacks DB; Kowalski A; Brown AS; Heinemann L; Aleppo G; Ryan DB; Riddlesworth TD; Cefalu WT
    Diabetes Care; 2018 Nov; 41(11):2275-2280. PubMed ID: 30224348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interprofessional collaboration to improve care for patients with diabetes.
    Gulley T; Cole R; Subbanna M; Ratliff CC; Hill-Collins P; Tyson T
    Nurse Pract; 2024 May; 49(5):34-39. PubMed ID: 38662495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 Diabetes - A Clinical Perspective.
    Kahanovitz L; Sluss PM; Russell SJ
    Point Care; 2017 Mar; 16(1):37-40. PubMed ID: 28943810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes.
    Poolsup N; Suksomboon N; Kyaw AM
    Diabetol Metab Syndr; 2013; 5():39. PubMed ID: 23876067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous glucose monitoring: evidence and consensus statement for clinical use.
    Liebl A; Henrichs HR; Heinemann L; Freckmann G; Biermann E; Thomas A;
    J Diabetes Sci Technol; 2013 Mar; 7(2):500-19. PubMed ID: 23567009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Satisfaction with the Use of Different Technologies for Insulin Delivery and Glucose Monitoring Among Adults with Long-Standing Type 1 Diabetes and Problematic Hypoglycemia: 2-Year Follow-Up in the HypoCOMPaSS Randomized Clinical Trial.
    Speight J; Holmes-Truscott E; Little SA; Leelarathna L; Walkinshaw E; Tan HK; Bowes A; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JAM
    Diabetes Technol Ther; 2019 Nov; 21(11):619-626. PubMed ID: 31335201
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
    Ajjan RA; Jackson N; Thomson SA
    Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
    Halbron M; Bourron O; Andreelli F; Ciangura C; Jacqueminet S; Popelier M; Bosquet F; Rouanet S; Amouyal C; Hartemann A
    Diabetes Technol Ther; 2019 Jul; 21(7):409-412. PubMed ID: 31265349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there an optimal strategy for real-time continuous glucose monitoring in pediatrics? A 12-month French multi-center, prospective, controlled randomized trial (Start-In!).
    Guilmin-Crépon S; Carel JC; Schroedt J; Sulmont V; Salmon AS; Le Tallec C; Coutant R; Dalla-Vale F; Stuckens C; Bony-Trifunovic H; Crosnier H; Kurtz F; Kaguelidou F; Le Jeannic A; Durand-Zaleski I; Couque N; Alberti C; Tubiana-Rufi N
    Pediatr Diabetes; 2019 May; 20(3):304-313. PubMed ID: 30663187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
    Chaugule S; Graham C
    J Med Econ; 2017 Nov; 20(11):1128-1135. PubMed ID: 28745578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping safe. Continuous glucose monitoring (CGM) in persons with Type 1 diabetes and impaired awareness of hypoglycaemia: a qualitative study.
    Vloemans AF; van Beers CAJ; de Wit M; Cleijne W; Rondags SM; Geelhoed-Duijvestijn PH; Kramer MHH; Serné EH; Snoek FJ
    Diabet Med; 2017 Oct; 34(10):1470-1476. PubMed ID: 28731509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with the Enlite sensor in a multicenter pediatric study.
    Evans K; Richardson C; Landry A; Muileboom J; Cormack L; Lawson ML;
    Diabetes Educ; 2015 Feb; 41(1):31-7. PubMed ID: 25512220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between mean glucose and time in range in relation to HbA
    Sterner Isaksson S; Imberg H; Hirsch IB; Schwarcz E; Hellman J; Wijkman M; Bolinder J; Nyström T; Holmer H; Hallström S; Ólafsdóttir AF; Pekkari S; Polonsky W; Lind M
    Diabetologia; 2024 Apr; ():. PubMed ID: 38668761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.